After stepping down as CEO of Eternal Ltd. in February, Deepinder Goyal is focusing on ambitious projects in health technology and aerospace, with plans to launch a new wearable device called Temple and back aviation startup LAT Aerospace.
Temple, a bean-shaped wearable designed to be worn on the side of the forehead, is being developed as a wellness device capable of measuring the body’s metabolic state in real time. Goyal said the product could be launched within six months to a year and would be supported by peer-reviewed studies.
The device emerged from a personal research project focused on cerebral blood flow and has led Goyal’s team to develop what he describes as a new biomarker, called “entropy,” which he believes can provide insights into stress, recovery, sleep, exercise and meditation by directly tracking metabolic activity. However, the science behind the metric has yet to be independently validated.
Temple will enter a rapidly expanding wearables market currently dominated by smartwatches, fitness bands and smart rings that track metrics such as heart rate, sleep quality and recovery. Goyal argues that most existing devices use heart rate as an indirect indicator of what is happening inside the body, while Temple is designed to measure metabolic rate directly. The device has not yet undergone medical regulatory approval.
Priced at around $1,000, Temple is expected to target athletes, founders, executives and other high-performance users rather than the broader consumer market. It will also be the first commercial product to emerge from Goyal’s ventures outside the Eternal ecosystem.
Outside of health tech, Goyal is also getting into aviation through LAT Aerospace, a startup that is focused on next-generation regional aviation solutions. He has invested $20 million into the startup, suggesting he’s interested in high-risk, long-term technology plays outside of consumer internet companies.
With a net worth of $1.3 billion, much of it tied to his stake in Eternal, Goyal seems to be putting his money into experimental technologies ranging from wellness and longevity research to aerospace innovation.
First Published on
